Tango Therapeutics Inc. (TNGX)
NASDAQ · Healthcare
Tango Therapeutics Inc. EPS 2020–2025
Tango Therapeutics Inc. annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Tango Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.32, a 11.11% decrease year-over-year.
- Tango Therapeutics Inc. annual eps for 2025 was $0.87, a 26.89% decrease from 2024.
- Tango Therapeutics Inc. annual eps for 2024 was $1.19, a 10.19% increase from 2023.
- Tango Therapeutics Inc. annual eps for 2023 was $1.08, a 12.20% decrease from 2022.
- Tango Therapeutics Inc. annual eps for 2022 was $1.23.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Tango Therapeutics Inc. EPS — FAQ
Tango Therapeutics Inc. (TNGX) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Tango Therapeutics Inc.'s eps?
Tango Therapeutics Inc. (TNGX) reported eps of $-0.87 for fiscal 2025.
Where can I see TNGX's eps history?
The chart and table above show Tango Therapeutics Inc.'s eps by year and by quarter, including the growth rate.